Iclusig 45 mg, comprimés pelliculés - 30 Tablette(n) Swissmedic Key 63097002 PP Registration Holder Incyte Biosciences International Sàrl Name Iclusig 45 mg, comprimés pelliculés Date of registration 12.02.2014 Introduction of Sequence 12.02.2014 ATC-Classification Ponatinib (L01EA05) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size 30 Tablette(n) Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 4854.18 Limitation Yes Limitation text
Deductible 10 % Consumer price 5288.20 Feedback FB GTIN 7680630970022 Medication Code Synthetika Pharmacode Disponibility
Composition ponatinibum 40 mg ut ponatinibi hydrochloridum, lactosum monohydricum 120.45 mg, cellulosum microcristallinum, carboxymethylamylum natricum corresp. natrium 0.528 mg, silica colloidalis anhydrica, magnesii stearas, pellicule: talcum, macrogolum 4000, poly(alcohol vinylicus), E 171, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Ponatinibum 40 mg
BAG: Active Agent Dose Ponatinibum 45 mg
Inactive agents Dose additional_information Carboxymethylamylum Natricum Cellulosum Microcristallinum E 171 color. Lactose Monohydrate 120.45 mg Macrogol 4000 Magnesii Stearas Poly(Alcohol Vinylicus) Pro Compresso Obducto Silica Colloidalis Anhydrica Talcum pellicule
Source Data was imported : 07.02.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
